Filings

ASX Filings

Date	Description
February 20, 2024	Opthea Appoints Arshard M Khanani as Chief Medical Advisor
February 15, 2024	Opthea Completes Enrollment in First Trial of Sozinibercept
February 2, 2024	Opthea Strengthens Team with Key Clinical & Regulatory Hires
December 27, 2023	Opthea to Receive US$35M Commitment and Additional US$50M
December 21, 2023	Change of Director's Interest Notice - JL

There are no SEC filings available.

Data provided by Kaleidoscope.